Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-04-14FDA Approved: VERSACLOZ — Supplemental Application (TruPharma LLC)
The FDA approved a supplemental application for VERSACLOZ (clozapine) filed by TruPharma LLC. Clozapine is an antipsychotic indicated for sc…
-
CLINICAL_TRIALS trial_result · 2020-04-13Clinical Trial Update: Adapted Cognitive/Affective Remediation for Cannabis Misuse in Schizophrenia [Phase 1, Phase 2]
A Phase 1/2 clinical trial investigating adapted cognitive/affective remediation for cannabis misuse in individuals with schizophrenia or sc…
-
CLINICAL_TRIALS trial_result · 2020-04-13Clinical Trial Update: Aripiprazole, Abilify Maintena Collaborative Clinical Protocol [NA]
Clinical trial update for aripiprazole Abilify Maintena collaboration; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2020-04-08Clinical Trial Update: Naltrexone for Antipsychotic-Induced Weight Gain [NA]
Clinical trial update for naltrexone addressing antipsychotic-induced weight gain; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-04-07Clinical Trial Update: Treatment of Schizophrenia With L-tetrahydropalmatine (l-THP): a Novel Dopamine Antagonist With Anti-inflammatory and Antiprotozoal Activity [NA]
A completed clinical trial evaluating L-tetrahydropalmatine (l-THP), a dopamine antagonist with anti-inflammatory and antiprotozoal activity…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-04-06FDA Approved: PERPHENAZINE — Original Application (Zydus Pharmaceuticals (USA) Inc.)
FDA approved the original ANDA for Perphenazine by Zydus Pharmaceuticals (USA) Inc., enabling the manufacture and distribution of a generic …
-
CLINICAL_TRIALS trial_result · 2020-04-02Clinical Trial Update: Influence of Vitamin D Supplementation on Serum BDNF Level and Cognitive Function in Schizophrenia [Phase 3]
Phase 3 trial investigating whether vitamin D supplementation affects serum BDNF levels and cognitive function in schizophrenia.
-
CLINICAL_TRIALS trial_result · 2020-03-31Clinical Trial Update: Lurasidone Vs Olanzapine on Neurotrophic Biomarkers and Cardiometabolic Parameters in Unmedicated Schizophrenia [Phase 4]
Phase 4 clinical trial comparing lurasidone versus olanzapine in unmedicated schizophrenia focusing on neurotrophic biomarkers and cardiomet…
-
FDA label_change · 2020-03-27FDA Approved: SEROQUEL XR — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for SEROQUEL XR (quetiapine) from AstraZeneca, resulting in labeling updates for the drug.
-
CLINICAL_TRIALS trial_result · 2020-03-27Clinical Trial Update: Study to Assess Efficacy and Safety of HP3070 in Subjects Diagnosed With Schizophrenia. [Phase 3]
Phase 3 trial updating efficacy and safety data for HP3070 in schizophrenia has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-03-27Clinical Trial Update: MK-8189 Multiple Dose Study in Healthy Volunteers and Schizophrenia Participants (MK-8189-003) [Phase 1]
Phase 1 clinical trial update for MK-8189 in healthy volunteers and schizophrenia participants; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-03-26Clinical Trial Update: Psychosocial Therapy and Risperidone Treatment in Work Performance in Recent-Onset Schizophrenia [Phase 4]
Phase 4 trial update on psychosocial therapy combined with risperidone for work performance in recent-onset schizophrenia; results completed…
-
CLINICAL_TRIALS trial_result · 2020-03-26Clinical Trial Update: The Effect of Sertindole and Risperidone on Endophenotypic Markers of Schizophrenia [Phase 4]
Phase 4 trial evaluating the effect of sertindole and risperidone on endophenotypic markers in schizophrenia; the study status is terminated…
-
CLINICAL_TRIALS trial_result · 2020-03-24Clinical Trial Update: A 6-month Study to Evaluate Sulforaphane add-on Effects in Treatment of Schizophrenia [Phase 2]
A Phase 2 trial evaluating sulforaphane as an add-on therapy for schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2020-03-23Clinical Trial Update: Oral Versus Injectable Risperidone for Treating First-Episode Schizophrenia [Phase 4]
Phase 4 trial comparing oral versus injectable risperidone for first-episode schizophrenia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-03-23Clinical Trial Update: TDCS for Auditory Hallucinations in Schizophrenia [NA]
A completed clinical trial evaluating transcranial direct current stimulation (TDCS) for auditory hallucinations in schizophrenia has posted…
-
CLINICAL_TRIALS trial_result · 2020-03-19Clinical Trial Update: Virtual Reality Training for Social Skills in Schizophrenia [NA]
Completed clinical trial evaluating virtual reality training to improve social skills in individuals with schizophrenia; results posted in 2…
-
FDA approval · 2020-03-11FDA Approved: ZIPRASIDONE HYDROCHLORIDE — Supplemental Application (Apotex Corp.)
FDA approved Apotex Corp.'s supplemental application for ziprasidone hydrochloride under an ANDA. This action supports a generic version of …
-
FDA approval · 2020-02-20FDA Approved: ARIPIPRAZOLE — Supplemental Application (Dr.Reddys Laboratories Inc)
The FDA approved a supplemental application for aripiprazole from Dr. Reddy's Laboratories Inc., supporting regulatory action for the generi…
-
CLINICAL_TRIALS trial_result · 2020-02-19Clinical Trial Update: Safety and Tolerability of Risperidone Implants [Phase 3]
A Phase 3 trial update reports safety and tolerability data for risperidone implants in schizophrenia, with results posted after completion.
-
CLINICAL_TRIALS trial_result · 2020-02-19Clinical Trial Update: Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant [Phase 2]
Phase 2 trial assessing pharmacokinetics of risperidone and 9-hydroxy risperidone from a polyurethane implant in stabilized schizophrenic pa…
-
CLINICAL_TRIALS trial_result · 2020-02-18Clinical Trial Update: The Street Smart Group: A Feasibility Trial of a Group Intervention Targeting Anxiety Processes in Paranoia [Phase 2]
Phase 2 feasibility trial of a group intervention targeting anxiety processes in paranoia (paranoia and schizophrenia-spectrum conditions) c…
-
CLINICAL_TRIALS trial_result · 2020-02-12Clinical Trial Update: Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 1-year Follow-up [Phase 4]
Phase 4 trial update assessing the effectiveness of second generation antipsychotics in first-episode psychosis with a 1-year follow-up.
-
CLINICAL_TRIALS trial_result · 2020-02-10Clinical Trial Update: A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study) [Phase 3]
Phase 3 clinical trial ENLIGHTEN-2 evaluating ALKS 3831 in adults with schizophrenia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-02-10Clinical Trial Update: Modulating Human Cortical Plasticity With Transcranial Electrical Stimulation [NA]
Clinical trial assessing modulation of human cortical plasticity using transcranial electrical stimulation; completed with results posted in…